Results 161 to 170 of about 233,338 (314)

Effects of linagliptin on left ventricular DYsfunction in patients with type 2 DiAbetes and concentric left ventricular geometry: results of the DYDA 2 trial [PDF]

, 2020
Giovanni Cioffi, Carlo Giorda, Donata Lucci, Elisa Nada, Federica Ognibeni, Costantino Mancusi, Roberto Latini, Aldo P. Maggioni, the DYDA 2 investigators   +8 more
openalex   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source

Revascularization in Ischemic Left Ventricular Dysfunction: From Risk to Reality. [PDF]

J Soc Cardiovasc Angiogr Interv
Redfors B, Jha S, Omerovic E.
europepmc   +1 more source

Chronic coronary artery constriction leads to moderate myocyte loss and left ventricular dysfunction and failure in rats. [PDF]

, 1992
Piero Anversa, X Zhang, Peng Li, J. M. Capasso   +3 more
openalex   +1 more source

Left ventricular dysfunction in the newborn

Translational Pediatrics, 2023
Menahem, Samuel, Sehgal, Arvind
openaire   +2 more sources

An open‐label, single‐arm, dose‐escalating concentration–QT study to investigate the cardiac effects and safety of paroxetine in healthy adults

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Paroxetine is a selective serotonin reuptake inhibitor (SSRI), approved for treatment of major depressive disorder and anxiety disorders. Some SSRIs are known to prolong the QT interval; however, clinical evidence to establish a lack of association between paroxetine and corrected QT interval (QTc) prolongation is limited. Therefore, this
Sven C. van Dijkman, Mathieu Félices, Bhaskar Pandurangavittal, Sanman Ghorpade, Caroline Easterbrook, Marcin Zabielski, Oscar Della Pasqua   +6 more
wiley   +1 more source

Apixaban and Recurrent Stroke Risk With Left Ventricular Dysfunction: A Secondary Analysis of the ARCADIA Trial. [PDF]

Stroke
Sharma R, Jillella D, Zhang C, Elkind MSV, Kamel H, Di Tullio MR, Kronmal RA, Krishnaiah B, Yaghi S, Longstreth WT, Tirschwell DL, Merkler AE, Nahab F.   +12 more
europepmc   +1 more source

Clinical pharmacology and prescribing education: An updated medical school curriculum from the British Pharmacological Society

British Journal of Clinical Pharmacology, EarlyView.
Aims Prescribing is a complex, essential skill that doctors must acquire to practice medicine safely and effectively. The British Pharmacological Society has historically provided a core curriculum to guide clinical pharmacology and prescribing education in UK medical schools.
Dagan O. Lonsdale, Clare Guilding, Jennifer Koenig, Michael Okorie, Reecha Sofat, Simon Maxwell   +5 more
wiley   +1 more source

Comparison of the correlation between triglyceride-glucose index and homeostasis model assessment of insulin resistance with subclinical left ventricular dysfunction. [PDF]

J Diabetes Investig
Zhou T, Wang X, Yan X, Guo W, Pi Z, Liang J, Gao Y, Zhang S, Hua M, Chen C, Zhao X, Liu M.   +11 more
europepmc   +1 more source

Left Ventricular Systolic Dysfunction [PDF]

, 2020
openaire   +1 more source